Search Medical Condition
Please enter condition
Please choose location

Emmendingen, Germany Clinical Trials

A listing of Emmendingen, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (54) clinical trials

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

0.6 miles

Learn More »

Non-interventional Study With NOVOCART Inject in the Reconstruction of the Knee Cartilage Defects

Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint. Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time. Efficacy: Evaluate symptoms and functional status at ...

Phase N/A

5.2 miles

Learn More »

Tumour Registry Colorectal Cancer

The TKK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At ...

Phase N/A

5.34 miles

Learn More »

This clinical trial is provided by TrialReach. The purpose of this study is to find out whether the drug is safe Tralokinumab, improved asthma symptoms or asthma attacks in asthmatic patients where standard medication does not hit, relieves.

Phase

5.7 miles

Learn More »

One Pass thalamIc aNd subthalamIc stimulatiON

Tremor is the most salient symptom of Parkinson's disease (IPS=idiopathic Parkinson syndrome). Other symptoms are bradykinesia, rigidity and postural instability. As much as 75% of patients with IPS show resting tremor. Initially, tremor is typically unilateral and only visible in stress situation. In the later stage of the disease it ...

Phase N/A

6.91 miles

Learn More »

Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix and FOLFIRI in First Line (VALIDATE)

This is a non-interventional, prospective, open-label, single-arm, 3-cohort, multicenter study in Germany. In total, 1,240 patients will be enrolled in 100 oncological sites (office-based medical oncologists, oncology outpatient-centers, and university hospitals) in a time period of 36 months. Of these, 420 patients with high risk, 420 patients with intermediate risk, ...

Phase N/A

6.91 miles

Learn More »

Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

This is a Phase 2/3, multicenter study of imetelstat that consists of 2 parts. Part 1 is an open‐label, single-arm design to assess the efficacy and safety of imetelstat. Approximately 55 participants will be enrolled in Part 1, including the expansion cohort, and be followed-up for safety, hematologic improvement and ...

Phase

7.82 miles

Learn More »

European Multicenter Randomized Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent

Occlusive coronary artery disease is predominantly caused by coronary atherosclerosis, a pathologic vascular condition characterized by abnormal lipid and fibrous tissue accumulation in the vessel wall. This condition may be accompanied by degenerative changes and/or calcification leading to stenosis (narrowing) of the luminal channel. Percutaneous Transluminal Coronary Angioplasty (PTCA) is ...

Phase

7.82 miles

Learn More »